chr1-240806305-G-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001364886.1(RGS7):c.1104C>A(p.Asp368Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000954 in 1,613,628 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001364886.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RGS7 | NM_001364886.1 | c.1104C>A | p.Asp368Glu | missense_variant | 15/19 | ENST00000440928.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RGS7 | ENST00000440928.6 | c.1104C>A | p.Asp368Glu | missense_variant | 15/19 | 1 | NM_001364886.1 |
Frequencies
GnomAD3 genomes AF: 0.0000790 AC: 12AN: 151906Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000115 AC: 29AN: 251084Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135704
GnomAD4 exome AF: 0.0000971 AC: 142AN: 1461722Hom.: 0 Cov.: 31 AF XY: 0.0000894 AC XY: 65AN XY: 727170
GnomAD4 genome AF: 0.0000790 AC: 12AN: 151906Hom.: 0 Cov.: 32 AF XY: 0.0000674 AC XY: 5AN XY: 74184
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.1104C>A (p.D368E) alteration is located in exon 15 (coding exon 14) of the RGS7 gene. This alteration results from a C to A substitution at nucleotide position 1104, causing the aspartic acid (D) at amino acid position 368 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at